Mark Corrigan Net Worth & Insider Trades

Mark Corrigan - Director, Nabriva Therapeutics Plc

As of August 4, 2022

What is Mark Corrigan's Net Worth?

The current estimated net worth of Nabriva Therapeutics Plc's Director, Mark Corrigan, is estimated to be about $39.5K . Mark Corrigan owns about 7,203 units of Nabriva Therapeutics Plc common stock. In the last 5 years at Nabriva Therapeutics Plc, Mark Corrigan has sold an estimated value of $1.96K worth.

What is Mark Corrigan's Past Insider Trading?

Mark Corrigan's largest sale order was 10,297 units , worth over $1.96K on August 4, 2022. In total, Mark Corrigan has made about 7 transactions over 5 years of their time at Nabriva Therapeutics Plc. Mark Corrigan usually trades in August and June, with the busiest year in 2021 and 2017.

MARK CORRIGAN

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Nabriva Therapeutics Plc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Theodore Schroeder 2020 $576,800 - $242,256 $339,625 $242,256 $31,759 $1,654,570
Theodore Schroeder 2019 $560,000 - $119,250 $478,367 $119,250 $28,372 $1,496,164
Steven Gelone 2020 $486,300 - $153,185 $231,493 $153,185 $12,675 $1,154,516
Steven Gelone 2019 $472,100 - $181,420 $309,859 $181,420 $13,976 $1,178,280
Jennifer Schranz 2020 $460,000 $100,000 $145,203 $156,818 $145,203 $28,604 $1,074,113
Jennifer Schranz 2019 $436,200 - $151,200 $261,555 $151,200 $33,450 $982,155
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1641640/000110465921088033/tm2119969-2_def14a.htm

What are Nabriva Therapeutics Plc's Past Insider Trades?

Nabriva Therapeutics Plc's most recent insider trade came on August 4, 2022 by Daniel Burgess who sold 11,341 units worth $2.16K . In the last 5 years, insiders at Nabriva Therapeutics Plc have sold an estimated value of $5.26M and bought an estimated value of $1.22M worth of shares. Insider trading is most common in August, with the busiest year in 2021. The most active traders at the company are Steven Gelone, President and COO,  Theodore Schroeder, Chief Executive Officer,  and Robert Crotty, Gen Counsel & Corp Secretary .

Nabriva Therapeutics plc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1